Trofinetide Completed Phase 1 Trials for Brain Injuries,Traumatic Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00961779Safety Study of NNZ-2566 in Healthy Female Subjects
NCT01420042Safety Study of NNZ-2566 in Healthy Subjects, Following Oral Administration